Physician profile
Arpit Agrawal
NPI 1386872257
$5,057.81
in general payments reported to CMS, 2019-2025
18 companies · $1,779 in 2025
The $1,779 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $379 · 2020: $259 · 2021: $282 · 2022: $542 · 2023: $574 · 2024: $1,242 · 2025: $1,779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,915 · Food and Beverage: $1,680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,914.89 |
| Food and Beverage | $1,680.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,199.40 | 2019-2025 | Pascal, Evoque |
| Abbott Laboratories | $1,147.19 | 2022-2024 | Navitor, Mitraclip |
| Boston Scientific Corporation | $639.57 | 2021-2022 | |
| Heartflow, INC. | $451.12 | 2020-2024 | Ffrct |
| Medtronic Vascular, INC. | $119.74 | 2019 | |
| Novartis Pharmaceuticals Corporation | $107.72 | 2019-2020 | |
| Amgen INC. | $71.43 | 2019-2023 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $66.08 | 2023-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $48.91 | 2024 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $46.86 | 2019-2025 | Camzyos |
| Ge Healthcare | $36.18 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $25.90 | 2019-2020 | |
| Pfizer INC. | $23.41 | 2019 | |
| Lantheus Medical Imaging, INC. | $21.87 | 2025 | |
| Sanofi-Aventis U.S. LLC | $16.63 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ancora Heart, INC. | $13.00 | 2023 | Accucinch |
| Gilead Sciences, INC. | $11.72 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arpit Agrawal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.